Skip to main content

Hematological Oncology

Hematological Oncology

Edited By:Francesco Bertoni

Print ISSN: 0278-0232 Online ISSN: 1099-1069 Impact Factor: 3.193


Effective with the 2011 volume, this journal will be published in an online-only format

Hematological Oncology considers for publication articles dealing with experimental and clinical aspects of neoplastic diseases of the hemopoietic and lymphoid systems and relevant related matters. Translational studies applying basic science to clinical issues are particularly welcomed. Manuscripts dealing with the following areas are encouraged:

  • Clinical practice and management of hematological neoplasia, including: acute and chronic leukemias, malignant lymphomas, myeloproliferative disorders
  • Diagnostic investigations, including imaging and laboratory assays
  • Epidemiology, pathology and pathobiology of hematological neoplasia of hematological diseases
  • Therapeutic issues including Phase 1, 2 or 3 trials as well as allogeneic and autologous stem cell transplantation studies
  • Aspects of the cell biology, molecular biology, molecular genetics and cytogenetics of normal or diseased hematopoeisis and lymphopoiesis, including stem cells and cytokines and other regulatory systems

Concise, topical review material is welcomed, especially if it makes new concepts and ideas accessible to a wider community. Proposals for review material may be discussed with the Editor-in-Chief. Collections of case material and case reports will be considered only if they have broader scientific or clinical relevance.

2009 Impact Factor: 2.475 (© Thomson Reuters Citation Reports 2010)